• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肌肉表现和 COVID 感染时的 CK 水平:大流行 COVID-19 区大量患者的结果。

Muscle manifestations and CK levels in COVID infection: results of a large cohort of patients inside a Pandemic COVID-19 Area.

机构信息

Neurology-Stroke Unit, AO Ospedale Civile di Legnano, ASST Ovest Milanese, Legnano, Italy.

Neurology Unit, Department of Clinical and Experimental Medicine University of Pisa, Italy.

出版信息

Acta Myol. 2021 Mar 31;40(1):1-7. doi: 10.36185/2532-1900-040. eCollection 2021 Mar.

DOI:10.36185/2532-1900-040
PMID:33870093
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8033429/
Abstract

OBJECTIVE

To investigate both muscular manifestations and CK levels in a large cohort of patients with COVID-19 infection and to determine whether hyperckemia is associated with morbidity and mortality.

METHODS

Data of 615 patients discharged from ASST Ovest Milanese (Milan, Lombardy, Italy) with final diagnosis of COVID-19 infection were retrospectively extracted from electronical medical records from 21 February to 1 May 2020. Patients were descriptively analyzed with respect to the following variables: sex, age, muscular manifestations (myalgia and/or arthralgia), fatigue, respiratory involvement (SARS pneumonia or respiratory failure) and history of falls. Association between patients' characteristics and CK levels was investigated. In addition, the proportion of patients who died following access to the ER was calculated. Finally, the effect of CK levels and other patients' features on mortality was estimated using a logistic regression model.

RESULTS

176 (28.6%) patients had raised serum CK levels. CK levels were significantly associated with history of falls, male gender, SARS pneumonia, respiratory failure and in-hospital death. No correlation was found between hyperckemia and muscular manifestations.

CONCLUSIONS

Our study provides preliminary evidence that hyperckemia is associated with respiratory failure and fatal outcome in patients with COVID-19 infection.In these patients, among other testing, CK dosage is recommended.

摘要

目的

研究大量 COVID-19 感染患者的肌肉表现和 CK 水平,并确定高 CK 是否与发病率和死亡率相关。

方法

从 2020 年 2 月 21 日至 5 月 1 日从电子病历中回顾性提取了来自 ASST Ovest Milanese(意大利伦巴第大区米兰)的 615 名出院的 COVID-19 感染患者的数据。患者根据以下变量进行描述性分析:性别、年龄、肌肉表现(肌痛和/或关节痛)、疲劳、呼吸受累(SARS 肺炎或呼吸衰竭)和跌倒史。研究了患者特征与 CK 水平之间的关系。此外,计算了进入急诊室后死亡的患者比例。最后,使用逻辑回归模型估计 CK 水平和其他患者特征对死亡率的影响。

结果

176 名(28.6%)患者的血清 CK 水平升高。CK 水平与跌倒史、男性、SARS 肺炎、呼吸衰竭和院内死亡显著相关。高 CK 血症与肌肉表现之间无相关性。

结论

我们的研究提供了初步证据,表明 COVID-19 感染患者的高 CK 血症与呼吸衰竭和致命结局相关。在这些患者中,建议除其他检查外,还应进行 CK 检测。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229a/8033429/d629ea508a8a/am-2021-01-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229a/8033429/41f271e49e73/am-2021-01-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229a/8033429/d629ea508a8a/am-2021-01-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229a/8033429/41f271e49e73/am-2021-01-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/229a/8033429/d629ea508a8a/am-2021-01-1-g002.jpg

相似文献

1
Muscle manifestations and CK levels in COVID infection: results of a large cohort of patients inside a Pandemic COVID-19 Area.肌肉表现和 COVID 感染时的 CK 水平:大流行 COVID-19 区大量患者的结果。
Acta Myol. 2021 Mar 31;40(1):1-7. doi: 10.36185/2532-1900-040. eCollection 2021 Mar.
2
Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy.意大利伦巴第地区 1591 名 ICU 收治的 SARS-CoV-2 感染患者的基线特征和结局。
JAMA. 2020 Apr 28;323(16):1574-1581. doi: 10.1001/jama.2020.5394.
3
Muscle involvement in SARS-CoV-2 infection.肌肉在 SARS-CoV-2 感染中的作用。
Eur J Neurol. 2021 Oct;28(10):3411-3417. doi: 10.1111/ene.14564. Epub 2020 Oct 25.
4
Early neurological manifestations of hospitalized COVID-19 patients.住院 COVID-19 患者的早期神经表现。
Neurol Sci. 2020 Aug;41(8):2029-2031. doi: 10.1007/s10072-020-04525-z. Epub 2020 Jul 2.
5
Assessment of musculoskeletal pain, fatigue and grip strength in hospitalized patients with COVID-19.评估 COVID-19 住院患者的肌肉骨骼疼痛、疲劳和握力。
Eur J Phys Rehabil Med. 2021 Aug;57(4):653-662. doi: 10.23736/S1973-9087.20.06563-6. Epub 2021 Jan 4.
6
Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.意大利瓦尔卡莫尼卡地区预测 2019 年冠状病毒病(COVID-19)死亡的实验室指标。
Clin Chem Lab Med. 2020 Jun 25;58(7):1100-1105. doi: 10.1515/cclm-2020-0459.
7
Risk Factors Associated With Mortality Among Patients With COVID-19 in Intensive Care Units in Lombardy, Italy.意大利伦巴第地区重症监护病房中 COVID-19 患者死亡的相关危险因素。
JAMA Intern Med. 2020 Oct 1;180(10):1345-1355. doi: 10.1001/jamainternmed.2020.3539.
8
Viral arthralgia a new manifestation of COVID-19 infection? A cohort study of COVID-19-associated musculoskeletal symptoms.病毒相关性关节炎:COVID-19 感染的新表现?一项 COVID-19 相关肌肉骨骼症状的队列研究。
Int J Infect Dis. 2021 Mar;104:363-369. doi: 10.1016/j.ijid.2021.01.031. Epub 2021 Jan 18.
9
Differences in hub and spoke vascular units practice during the novel Coronavirus-19 (COVID-19) outbreak in Lombardy, Italy.意大利伦巴第大区新型冠状病毒病(COVID-19)爆发期间枢纽与分支血管单位实践的差异。
J Cardiovasc Surg (Torino). 2021 Feb;62(1):71-78. doi: 10.23736/S0021-9509.20.11564-7. Epub 2020 Sep 23.
10
Complications and mortality in a cohort of patients undergoing emergency and elective surgery with perioperative SARS-CoV-2 infection: an Italian multicenter study. Teachings of Phase 1 to be brought in Phase 2 pandemic.围手术期 SARS-CoV-2 感染行急诊和择期手术患者的并发症和死亡率:一项意大利多中心研究。第 1 阶段的经验教训将引入第 2 阶段大流行。
Updates Surg. 2021 Apr;73(2):745-752. doi: 10.1007/s13304-020-00909-0. Epub 2021 Jan 3.

引用本文的文献

1
Urinary Metabolites Variation After High-Intensity Rowing Training and Potential Biomarker Screening for Exercise-Induced Muscle Damage.高强度划船训练后尿代谢物变化及运动诱导肌肉损伤潜在生物标志物筛查
Int J Mol Sci. 2025 Aug 15;26(16):7897. doi: 10.3390/ijms26167897.
2
Serological Biomarkers in Individuals with Interstitial Lung Disease after SARS-CoV-2 Infection and Association with Post-COVID-19 Symptoms.新型冠状病毒感染后间质性肺疾病患者的血清生物标志物及其与新冠后遗症的关联
Pathogens. 2024 Jul 31;13(8):641. doi: 10.3390/pathogens13080641.
3
Recurrent Rhabdomyolysis Induced by a Viral Illness in a Young Patient.

本文引用的文献

1
The impact of SARS-CoV-2 on skeletal muscles.严重急性呼吸综合征冠状病毒 2 型对骨骼肌的影响。
Acta Myol. 2020 Dec 1;39(4):307-312. doi: 10.36185/2532-1900-034. eCollection 2020 Dec.
2
Muscle involvement in SARS-CoV-2 infection.肌肉在 SARS-CoV-2 感染中的作用。
Eur J Neurol. 2021 Oct;28(10):3411-3417. doi: 10.1111/ene.14564. Epub 2020 Oct 25.
3
Neuromuscular presentations in patients with COVID-19.COVID-19 患者的神经肌肉表现。
一名年轻患者因病毒感染诱发复发性横纹肌溶解症。
Cureus. 2024 Jan 20;16(1):e52625. doi: 10.7759/cureus.52625. eCollection 2024 Jan.
4
The Characteristics and Laboratory Findings of SARS-CoV-2 Infected Patients during the First Three COVID-19 Waves in Portugal-A Retrospective Single-Center Study.葡萄牙前三次 COVID-19 浪潮中感染 SARS-CoV-2 患者的特征和实验室检查结果:一项回顾性单中心研究。
Medicina (Kaunas). 2023 Dec 28;60(1):59. doi: 10.3390/medicina60010059.
5
A single-center retrospective study of hospitalized COVID-19 patients: demographics, laboratory markers, neurological complications, ICU admission, and mortality.一项关于住院COVID-19患者的单中心回顾性研究:人口统计学、实验室指标、神经系统并发症、入住重症监护病房情况及死亡率。
Ann Med Surg (Lond). 2023 Jun 12;85(7):3323-3333. doi: 10.1097/MS9.0000000000000949. eCollection 2023 Jul.
6
COVID-19 Biomarkers Comparison: Children, Adults and Elders.COVID-19 生物标志物比较:儿童、成人和老年人。
Medicina (Kaunas). 2023 May 3;59(5):877. doi: 10.3390/medicina59050877.
7
COVID-19 Inflammatory Markers and Vitamin D Relationship in Pediatric Patients.儿科患者中 COVID-19 炎症标志物与维生素 D 的关系
Life (Basel). 2022 Dec 28;13(1):91. doi: 10.3390/life13010091.
8
Rhabdomyolysis after COVID-19 Infection: A Case Report and Review of the Literature.COVID-19 感染后横纹肌溶解症:病例报告及文献复习。
Viruses. 2022 Oct 14;14(10):2255. doi: 10.3390/v14102255.
9
Detection of COVID-19-related biomarkers by electrochemical biosensors and potential for diagnosis, prognosis, and prediction of the course of the disease in the context of personalized medicine.电化学生物传感器检测 COVID-19 相关生物标志物及其在个性化医学背景下用于诊断、预后和预测疾病进程的潜力。
Anal Bioanal Chem. 2023 Mar;415(6):1003-1031. doi: 10.1007/s00216-022-04237-7. Epub 2022 Aug 16.
10
The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection.轻度至中度新冠病毒感染后的肌肉骨骼受累情况
Front Physiol. 2022 Mar 18;13:813924. doi: 10.3389/fphys.2022.813924. eCollection 2022.
Neurol Sci. 2020 Nov;41(11):3039-3056. doi: 10.1007/s10072-020-04708-8. Epub 2020 Sep 15.
4
Early neurological manifestations of hospitalized COVID-19 patients.住院 COVID-19 患者的早期神经表现。
Neurol Sci. 2020 Aug;41(8):2029-2031. doi: 10.1007/s10072-020-04525-z. Epub 2020 Jul 2.
5
Laboratory predictors of death from coronavirus disease 2019 (COVID-19) in the area of Valcamonica, Italy.意大利瓦尔卡莫尼卡地区预测 2019 年冠状病毒病(COVID-19)死亡的实验室指标。
Clin Chem Lab Med. 2020 Jun 25;58(7):1100-1105. doi: 10.1515/cclm-2020-0459.
6
A Rare Presentation of Coronavirus Disease 2019 (COVID-19) Induced Viral Myositis With Subsequent Rhabdomyolysis.2019冠状病毒病(COVID-19)引发的病毒性肌炎伴横纹肌溶解症的罕见病例
Cureus. 2020 May 12;12(5):e8074. doi: 10.7759/cureus.8074.
7
Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study.《纽约市 COVID-19 重症成人的流行病学、临床病程和结局:一项前瞻性队列研究》
Lancet. 2020 Jun 6;395(10239):1763-1770. doi: 10.1016/S0140-6736(20)31189-2. Epub 2020 May 19.
8
Clinical and epidemiological characteristics of 1420 European patients with mild-to-moderate coronavirus disease 2019.1420 例轻症至中症 2019 年冠状病毒病欧洲患者的临床和流行病学特征。
J Intern Med. 2020 Sep;288(3):335-344. doi: 10.1111/joim.13089. Epub 2020 Jun 17.
9
Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues.SARS-CoV-2 细胞受体基因 ACE2 在多种人类组织中的表达。
Infect Dis Poverty. 2020 Apr 28;9(1):45. doi: 10.1186/s40249-020-00662-x.
10
COVID-19 deaths in Lombardy, Italy: data in context.意大利伦巴第大区的新冠病毒疾病死亡病例:相关数据
Lancet Public Health. 2020 Jun;5(6):e310. doi: 10.1016/S2468-2667(20)30099-2. Epub 2020 Apr 25.